ASPC
NASDAQ · N/A
A Spac Iii Acquisition-Cl A
$10.25
0.00 (0.00%)
Open$10.30
Previous Close$10.25
Day High$10.30
Day Low$10.25
52W High$63.98
52W Low$10.30
Volume—
Avg Volume5.8K
Market Cap23.99M
P/E Ratio56.89
EPS$0.02
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.50M | 7.85M | 8.29M |
| Net Income | 1.08M | 1.10M | 1.18M |
| Profit Margin | 12.8% | 14.0% | 14.3% |
| EBITDA | 2.43M | 1.87M | 2.14M |
| Free Cash Flow | 1.08M | 827.7K | 1.22M |
| Rev Growth | +23.2% | +3.0% | +8.6% |
| Debt/Equity | 0.81 | 0.71 | 0.73 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.96 | -21.55% | — | 1.23B |
| PICS | Pics Nv | $6.96 | -3.06% | 3.7 | 888.97M |
| DMII | Drugs Made In America Acquis | $10.26 | +0.29% | 50.0 | 651.01M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.61 | +0.09% | 27.6 | 219.04M |
| CEPF | Cantor Equity Partners-Cl A | $10.35 | +0.00% | 41.5 | 589.79M |